LEADER 03098nas  2200637-a 450 
001 9910134113603321
005 20240112213020.0
011   $a1468-6694
035   $a(DE-599)ZDB2040523-6
035   $a(OCoLC)48407034
035   $a(CKB)111018467304014
035   $a(CONSER)--2002252924
035   $a(NjHacI)99111018467304014
035   $a(EXLCZ)99111018467304014
100   $a20011112b20002005  s--         -
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCurrent controlled trials in cardiovascular medicine /$fBioMed Central, PubMed Central
210   $a[London] $cBioMed Central$d2000-2005
210  1$aLondon :$cBioMed Central,$d[2000]
215   $a1 online resource
300   $aRefereed/Peer-reviewed
300   $aTitle from contents screen (viewed July 2, 2002).
311   $a1468-6708 
327   $aHypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins -- Comments on ALLHAT and doxazosin -- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? -- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight -- Debate: PCI vs CABG: a moving target, but we are gaining -- Debate: Should statin be used in patients with heart failure? -- Debate: Statins should be used in patients with heart failure -- Cytokines as new treatment targets in chronic heart failure -- Therapeutic angiogenesis for cardiovascular disease -- Distal protection devices during percutaneous coronary and carotid interventions -- Biventricular pacing in heart failure: update on results from clinical trials -- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) -- A new era in hypertension research: discussing the findings of ALLHAT.
517 1 $aCCTCVM
531   $aCURR CONTROL TRIALS CARDIOVASC MED
531 00$aCurr control trials cardiovasc med
531 0 $aCurr. control. trials, Cardiovasc. med.
606   $aCardiology$vPeriodicals
606   $aClinical trials$vPeriodicals
606   $aCardiology$2fast$3(OCoLC)fst00847121
606   $aClinical trials$2fast$3(OCoLC)fst00864429
606   $aCardiovascular Diseases$xtherapy
606   $aCardiovascular Diseases$xphysiopathology
608   $aPeriodicals.
608   $aControlled Clinical Trial.
608   $aPeriodicals.$2fast
610   $aCardiovascular Diseases
615  0$aCardiology
615  0$aClinical trials
615  7$aCardiology.
615  7$aClinical trials.
615 12$aCardiovascular Diseases$xtherapy.
615 22$aCardiovascular Diseases$xphysiopathology.
676   $a616
712 02$aNational Institutes of Health (U.S.).$bPubMed Central.
801  0$bNjHacI
801  1$bNjHacl
906   $aJOURNAL
912   $a9910134113603321
996   $aCurrent controlled trials in cardiovascular medicine$91946562
997   $aUNINA